415 reports of this reaction
4.1% of all POVIDONE IODINE reports
#2 most reported adverse reaction
ENDOPHTHALMITIS is the #2 most commonly reported adverse reaction for POVIDONE IODINE, manufactured by Alcon Laboratories, Inc.. There are 415 FDA adverse event reports linking POVIDONE IODINE to ENDOPHTHALMITIS. This represents approximately 4.1% of all 10,103 adverse event reports for this drug.
Patients taking POVIDONE IODINE who experience endophthalmitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ENDOPHTHALMITIS is moderately reported among POVIDONE IODINE users, representing a notable but not dominant share of adverse events.
In addition to endophthalmitis, the following adverse reactions have been reported for POVIDONE IODINE:
The following drugs have also been linked to endophthalmitis in FDA adverse event reports:
ENDOPHTHALMITIS has been reported as an adverse event in 415 FDA reports for POVIDONE IODINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ENDOPHTHALMITIS accounts for approximately 4.1% of all adverse event reports for POVIDONE IODINE, making it one of the most commonly reported side effect.
If you experience endophthalmitis while taking POVIDONE IODINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.